‘Stop ripping us off’: Novo Nordisk CEO defends weight loss drug pricing during Senate grilling
Novo Nordisk’s top executive faced a Senate grilling on Tuesday over the high prices of the company’s weight loss drug Wegovy and diabetes treatment Ozempic, as demand for both injections…